RxSight, Inc. — Director's Dealing 2026

Jan 30, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RxSight, Inc. (RXST)
CIK: 0001111485
Period of Report: 2026-01-12

Reporting Person: Wilterding Mark (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2026-01-12	Stock Option (right to buy)	$10.09	A	258770	Acquired	2036-01-11	Common Stock (258770)	Direct
2026-01-12	Restricted Stock Unit	$	A	163528	Acquired		Common Stock (163528)	Direct

Footnotes

F1: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one-year anniversary of January 11, 2026 (the "Vesting Commencement Date"), and the remaining shares subject to the options shall vesting equally monthly on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month) over the following three years, such that all of the shares subject to the option shall be fully vested four years from the Vesting Commencement Date.

F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F3: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one eighth (1/8th) of the shares subject to the RSU award will vest on February 28, 2026, and one eighth (1/8th) of the shares subject to the RSU award will vest every six months thereafter on the last day of February and the last day of August over a four-year period.